InMode Ltd (INMD)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed product... InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States. Show more
InMode to Present at Upcoming Investor Conferences PR Newswire YOKNEAM, Israel, Aug. 6, 2024 YOKNEAM, Israel, Aug. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of...
InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered...
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform PR Newswire IRVINE, Calif., July 31, 2024 IRVINE, Calif., July 31, 2024 /PRNewswire/ -- InMode Ltd...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire MIAMI, July 25, 2024 Believes InMode's Cash Balance of Roughly 55% of its...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif., July 17, 2024 IRVINE, Calif., July 17, 2024...
InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024 PR Newswire YOKNEAM, Israel, July 11, 2024 Expects Q2 Revenue Between $86.2M-$86.3M, Pro-Forma...
InMode to Present at Jefferies Healthcare Conference PR Newswire YOKNEAM, Israel, May 16, 2024 YOKNEAM, Israel, May 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider...
InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand PR Newswire IRVINE, Calif., May 8, 2024 IRVINE, Calif., May 8, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a...
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.78 | -4.35510887772 | 17.91 | 18.6399 | 15.81 | 1929272 | 16.95620819 | CS |
| 4 | -0.09 | -0.522648083624 | 17.22 | 19.6 | 15.81 | 1437256 | 17.47328811 | CS |
| 12 | -1.735 | -9.19692552346 | 18.865 | 19.71 | 15.81 | 1291049 | 17.947818 | CS |
| 26 | -7.71 | -31.038647343 | 24.84 | 26.8 | 15.81 | 1426105 | 19.43485637 | CS |
| 52 | -25.84 | -60.1349778916 | 42.97 | 43.5 | 15.81 | 1611207 | 22.58120896 | CS |
| 156 | -99.6 | -85.3251092264 | 116.73 | 180 | 15.81 | 1628547 | 38.22095244 | CS |
| 260 | 3.58 | 26.4206642066 | 13.55 | 180 | 13.14 | 1350667 | 40.12863024 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
